SPECIAL NOTICE
A -- Human Clinical Trials for Infusible Hemostatic Agent
- Notice Date
- 5/11/2009
- Notice Type
- Synopsis
- NAICS
- 541711
— Research and Development in Biotechnology
- Contracting Office
- RDECOM Acquisition Center - Natick, ATTN: AMSRD-ACC-N, Natick Contracting Division (R and BaseOPS), Building 1, Kansas Street, Natick, MA 01760-5011
- ZIP Code
- 01760
- Solicitation Number
- EBUD3
- Archive Date
- 8/9/2009
- Point of Contact
- Peggy Dube, (508) 233-4481
- Small Business Set-Aside
- N/A
- Description
- Justification and Authorization for Research and Development of the preparation of Infusible Hemostatic Agent and conduction of related human clinical trials. NOTE: THIS NOTICE WAS NOT POSTED TO FEDBIZOPPS ON THE DATE INDICATED IN THE NOTICE ITSELF (11-MAY-2009); HOWEVER, IT DID APPEAR IN THE FEDBIZOPPS FTP FEED ON THIS DATE. PLEASE CONTACT 877-472-3779 or fbo.support@gsa.gov REGARDING THIS ISSUE.
- Web Link
-
Link To Document
(https://www.fbo.gov/spg/USA/USAMC/DAAD16/EBUD3/listing.html)
- Record
- SN01813932-F 20090513/090511233024 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |